Singulex, Inc., a biotechnology company, develops and commercializes direct molecular detection technology solutions. Its solutions enable life science researchers and clinicians to understand and manage disease. The company develops biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers. It is conducting pilot studies to validate Erenna BioAssay System, a digital molecule detection platform, which detects and quantifies molecule biomarkers in clinical samples. The company also offers various custom assay services, such as pilot study services, assay prototyping, assay characterization, and assay validation. The company was formerly known as BioProfile Corporation and changed its name to Singulex, Inc in September 2003. Singulex is based in Hayward, California
Company Growth (employees)
Alameda, US
Size (employees)
204 (est)
Singulex was founded in 2003 and is headquartered in Alameda, US

Key People/Management at Singulex

Guido Baechler

Guido Baechler

President and Chief Executive Officer
Peter Heseltine

Peter Heseltine

William Hammack

William Hammack

Vice President Human Resources
Jeffrey Bishop

Jeffrey Bishop

VP, Research and Development
Karen Richards

Karen Richards

VP, Regulatory Affairs and Quality Assurance

Singulex Office Locations

Singulex has an office in Alameda
Alameda, US (HQ)
1701 Harbor Bay Pkwy #200, CA 94502, USA
Show all (1)

Singulex Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$97.7 m

Latest funding size

$50 m

Time since last funding

over 1 year


Singulex's latest funding round in June 2016 was reported to be $50 m. In total, Singulex has raised $97.7 m

Singulex's Web-traffic and Trends

Singulex Online and Social Media Presence

Singulex Company Life and Culture

You may also be interested in